The histamine pathway metabolite differences that we identified in CML mice therefore prompted us to examine whether mast cells were increased in the GI tract of these animals, and if their presence was similarly regulated by IL-9. The gene discussed is IL9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.